期刊文献+

编码人IKK2dn重组腺病毒载体的构建及表达验证 被引量:1

Construction of Adenoviral Vector Encoding IKK2dn Gene and Identification of Their Expression
原文传递
导出
摘要 目的构建含有人IKK2dn基因的重组腺病毒载体,为转染未成熟树突状细胞(DC)诱导免疫耐受研究奠定基础。方法从质粒pACCMVPLPASR(+)-IKK2dn中酶切出IKK2dn基因,并插入pShuttle-CMV-GFP(-)TEMP载体中构建成腺病毒穿梭质粒,KpnI/HindⅢ酶切鉴定。将pShuttle-CMV-GFP(-)TEMP-IKK2dn转移到pAdxsi载体上,得到pAdxsi-GFP-IKK2dn病毒质粒,XhoI酶切后鉴定。将鉴定正确的质粒用脂质体法转染人胚肾细胞株HEK293细胞,包装成重组病毒颗粒;并在HEK293细胞中反复扩增并纯化,根据报告基因GFP测定病毒滴度。转染宫颈癌细胞株HeLa细胞后采用RT-PCR检测目的基因的表达。结果经酶切和RT-PCR鉴定,得到预期的1060bp条带,证实成功构建了携带IKK2dn基因的重组腺病毒载体,并制备出高滴度(2×1011PFU/ml)的重组腺病毒。结论成功构建了含IKK2dn-cDNA的重组腺病毒,为进一步研究用IKK2dn基因修饰DC诱导免疫耐受等研究奠定了基础。 Objective To construct the recombinant adenovirus vector encoding IKK2dn gene for using IKK2dn modified immature DC to induce immune tolerance.Methods IKK2dn cDNA was cloned into adenovirus transfer vector pShuttle-CMV-GFP(-)TEMP,and analyzed by restriction endonuclease KpnIHindIII digestion.Then,the obtained plasmid,pShuttle-CMV-GFP(-)TEMP-IKK2dn was transferred into pAdxsi vector to construct pAdxsi-GFP-IKK2dn plasmid,and was identified by XhoI digestion.The correct adenoviral recombinant was then cleaved with PacI and transfected into 293 cells to produce and purify viral particles.The virus was then transfected into hela cells,and the infection titer was monitored by green fluorescence protein(GFP)expression,IKK2dn gene was identified by RT-PCR.Results As confirmed by restriction digestion analysis and RT-PCR,an expectant fragment of 1060bp was observed in proper recombinants,it was proved that we successfully constructed the recombinant adenovirus vector encoding IKK2dn gene.The viral titer checked by GFP was about 2×1011pfu/ml.Conclusions The recombinant adenovirus vector encoding IKK2dn gene has been constructed successfully,which makes it easier to investigate the induction of immune tolerance by immature DC transfected by IKK2dn.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2010年第2期296-300,共5页 Suzhou University Journal of Medical Science
基金 江苏省医学重点人才基金项目(RC2007080) 江苏省"科教兴卫"医学重点实验室临床免疫学技术平台培育点基金项目
关键词 腺病毒载体 IKK2dn 树突状细胞 adenovirus vector IKK2dn dendritic cells
  • 相关文献

参考文献11

  • 1Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance [J]. Nat Rev Immunol, 2007,7 (8) :610 - 621.
  • 2Tiao MM, Lu L, Tao R, et al. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity[ J ]. Ann Surg,2005,241 (3) :497 -505.
  • 3Li M, Zhang X, Zheng X, et al. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference [ J ]. J Immunol, 2007,178 (9) : 5480 - 5487.
  • 4Andreakos E, Smith C, Monaco C, et al. I kappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction [ J ]. Blood,2003,101 (3) :983 - 991.
  • 5Lutz MB, Suri RM, Niimi M ,et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in viva [J]. Eur J Immunol, 2000,30 ( 7 ) : 1813 - 1822.
  • 6Aiello S, Cassis P, Cassis L, et al. DnIKK2-transfected dendritic cells induce a novel population of inducible nitric oxide synthase-expressing CD4 + CD25-cells with tolerogenic properties [ J ]. Transplantation, 2007,83 ( 4 ) : 474 - 484.
  • 7Barton K, Muthusamy N, Chanyangam M, et al. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB [ J ]. Nature, 1996,379 (6560) : 81 - 85.
  • 8Humrich J, Jenne L. Viral vectors for dendritic cell-based immunotherapy [J].Curr Top Microbiol Immunol, 2003, 276:241 - 259.
  • 9Benigni A, Remuzzi G. Gene therapy for renal diseases and transplantation[ J ]. Contrib Nephrol, 2008,159 ( 1 ) : 47 - 62.
  • 10Iju Q, Zaiss AK, Colarusso P,et al. The role of capsid- endothelial interactions in the innate immune response to adcnovirus vectors [ J ]. Hum Gene Ther, 2003,14 ( 7 ):627 - 643.

同被引文献8

  • 1李钊伦,田普训,薛武军,吴军,贺伟峰,易绍萱,陈希炜,张小容.sCD40LIg重组腺病毒载体的构建鉴定和体外表达[J].第三军医大学学报,2005,27(21):2107-2110. 被引量:3
  • 2Swohoda R K, Somasundaram R, Caputo L, et al. Shared MHC class Ⅱ-dependent melanonm ribosomal protein L8 identified hy phage display [J ]. Cancer Res, 2007,68(8):3555-3559.
  • 3Jennel L, Schuler G, Steinkasserer A. Viral vectors for dendrite cell-based immunotherapy [J]. Trends Immunol, 2001,22 (2) : 102-107.
  • 4Benigni A, Remuzzi G, Gene lherapy for venal disease and Iransplantalion [J ]. Contrib Nephrol, 2008,159( 1 ) :47-62.
  • 5Vorburger S A, Hunt K K. Adenoviral gene therapy [J]. Owcologist, 2002,7 ( 1 ) : 46-59.
  • 6Nadeau I, Kamen A. Production of adenovirus vector for gene therapy [J ]. Biotechnol Adv, 2003,20(7) : 475-489.
  • 7黄俊琼,张海峰,章春花,胡永林.IL-31重组腺病毒载体的构建及鉴定[J].临床和实验医学杂志,2008,7(6):17-19. 被引量:2
  • 8贾庆华,哈小琴,吕同德,刘春杰.携带KGF基因重组腺病毒载体的构建与鉴定[J].重庆医科大学学报,2011,36(1):64-67. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部